Retatrutide 4 mg is an investigational metabolic peptide attracting significant attention in obesity and weight‑management research. Unlike earlier therapies, Retatrutide acts as a triple receptor agonist, targeting GLP‑1, GIP, and glucagon receptors simultaneously. This multi‑pathway approach is designed to influence appetite regulation, glucose control, energy expenditure, and fat m... https://sites.lafayette.edu/evst315-fa14/2014/09/05/the-worst-mistake-in-the-history-of-the-human-race/#comment-115489